Key facts
- This page summarizes Jacob A. Orville's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Mar 2026, 18:56.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These shares represent a restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 2-year term, with 1/2 of the award vesting in any one year, beginning on March 23, 2027. The award includes the right to have shares withheld for tax purposes.